Planning Strategies’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$86.4K Buy
1,384
+23
+2% +$1.45K 0.05% 119
2026
Q2
$78.4K Buy
+1,361
New +$78.2K 0.05% 125

Other funds holding BMY

Planning Strategies's BMY Position: Q3 2026 in Review

Planning Strategies increased its Bristol-Myers Squibb (BMY) stake by 1.7% in Q3 2026, buying an estimated $1.45K and bringing the position to 1,384 shares worth $86.4K. The position accounts for 0.05% of the portfolio, ranked #119.

Planning Strategies first reported a position in BMY in Q2 2026 and has held it in 2 quarters since. 2,568 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Planning Strategies held 1,384 shares of Bristol-Myers Squibb worth $86.4K as of Q3 2026.
  • Planning Strategies bought 23 Bristol-Myers Squibb shares in Q3 2026, an estimated $1.45K.
  • Bristol-Myers Squibb made up 0.05% of Planning Strategies's portfolio in Q3 2026, its #119 holding.
  • Planning Strategies first reported a position in Bristol-Myers Squibb in Q2 2026 and has held it in 2 quarters since.
  • 2,568 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Planning Strategies's 13F filing for Q3 2026, filed 2 Oct 2026.